Previous Page  5 / 17 Next Page
Information
Show Menu
Previous Page 5 / 17 Next Page
Page Background

Page 18

Notes:

conferenceseries

.com

Volume 9, Issue 11 (Suppl)

J Cancer Sci Ther

ISSN: 1948-5956 JCST, an open access journal

Asia Pacific Oncologists 2017

November 20-22, 2017

November 20-22, 2017 Melbourne, Australia

14

th

Asia Pacific

Oncologists Annual Meeting

A systematic review of intramedullary spinal cord ependymoma and astrocytoma

Kirsty Hamilton

1

, Benjamin Jonker

2

and Sharon Lee

1

1

Sir Charles Gairdner Hospital, Australia

2

RPA-Institute of Academic Surgery, Australia

T

he true impact of surgical resection and adjuvant therapies on survival in intramedullary ependymoma and astrocytoma

is largely unknown. Searching of Medline, Embase and Clinicaltrials.gov databases were performed. Multivariate

analyses were performed for overall survival (OS) and progression-free survival (PFS) data sets. This was achieved through a

combination of Monte-Carlo methods and maximum likelihood estimation. 57 articles yielded results for 3022 patients. Gross-

total resection (GTR) reduces mortality in both ependymoma and astrocytoma by a factor of 5.1. An interaction was identified

between tumor grade and radiotherapy, such that for low-grade tumors, radiation treatment increased the risk of mortality 5.2

times, while for high-grade tumors radiotherapy decreased mortality by a factor of 1.9. High-grade tumors were associated

with a 12 times risk of death over low-grade tumors. Adult patients were more likely to die from their disease compared with

pediatric patients by a factor of 1.6. Regarding PFS, radiation treatment increased the rate of morbidity 1.9 times for both

pathologies. Gender did not influence survival. 79% of patients demonstrated stable or improved functional neurological

outcomes six months post-operatively. GTR improves OS in all tumor grades. Adjuvant radiation improves OS only in the

presence of high-grade histology. Advancing age and high-grade histology are negative prognostic indicators. Gender does not

influence survival.

Biography

Kirsty Hamilton is a Neurosurgical Trainee, currently practicing at the Princess Alexandra Hospital, Brisbane. Her research work deals with intra-medullary spinal

cord tumors, which was undertaken to address a knowledge gap in the literature for intramedullary tumor treatment strategies.

kirstypack@gmail.com

Kirsty Hamilton et al., J Cancer Sci Ther 2017, 9:11 (Suppl)

DOI: 10.4172/1948-5956-C1-117